Eucomed-MedTech

To read the article by Serge Bernasconi, Chief Executive Officer of MedTech Europe, Eucomed, EDMA : Got 5 minutes? Here’s MedTech Europe’s, EDMA’s and Eucomed’s 5 priorities for 2015

Most companies now think twice before taking groups of doctors to Disneyland — although a Croatian orthopedic firm was recently in trouble for promising trips to Las Vegas or Los Angeles as a reward for prescribing its products. But companies insist that they need to maintain links with doctors. EFPIA‘s own code says that doctors are the primary point of contact with patients. In the devices industry, where physicians physically manipulate and insert many products, personal experience is vital to feedback and to promoting innovation, say companies in the sector. Industry representatives in Europe largely contend that self-regulatory codes now …

Carolyn M. Bruguera, General Counsel and Vice President of Consulting Services, R-Squared Services and Solutions, Inc. In light of enforcement trends, compliance officers around the world are beefing up safeguards against corruption by third party intermediaries. For many, the task has been daunting. A large company may have hundreds or even thousands of distributors and sales agents around the world; in some cases just identifying them and implementing written contracts has been a massive undertaking. Small companies have fewer intermediaries, but also have fewer resources for managing their overseas agents and distributors. So where are we today? The task remains …

2015 is now well underway so there is no better time than right now to give you some insight into MedTech Europe‘s, EDMA‘s and Eucomed‘s priorities for 2015. To provide the most value for patients, healthcare professionals (HCPs), payers, policymakers and of course our members, I believe our 3 associations should this year focus on 5 key topics: • Value of medical technology; • Revision of the In Vitro Diagnostics Directive (IVDD) and Medical Devices Directive (MDD); • Health Technology Assessment (HTA) and Procurement; • Development new code of ethics including sponsorship of HCPs; • International Affairs. Extract: Sponsorship of HCPs: …

EDMA and Eucomed announced recommendations to respective members on how to improve their Codes of Ethical Business Practice. Chief among their recommendations are a phase out of direct sponsorship and stricter guidelines for indirect sponsorship of healthcare professionals to attend third-party organised conferences. They’ve also committed to working with stakeholders to elaborate new models of support for the continuing medical education of HCPs. What follows is my take on the future of CME. What is the current state of continuing medical education (CME)? Is CME itself – and the way it is being delivered – truly effective? To read the …

Associations recommend to members the phase out of direct sponsorship of healthcare professionals to third-party organised conferences and the implementation of more stringent guidance for indirect sponsorship. MedTech industry confirms its support to Continuing Medical Education and will intensify consultation process with relevant stakeholders to develop new models of engagement Brussels, 15 October 2014 – The Executive Committee of the European Diagnostics Manufacturers Association (EDMA) and the Board of the European Medical Technology Industry Association (Eucomed), both members of MedTech Europe, in a continuous effort to reinforce their respective Codes of Ethical Business Practice today announce their recommendation to members …